Respiratory Disease: Clinical Trials

5 trials for Respiratory Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Respiratory Disease: new trials by email Literature Review of Respiratory Disease trials Research Report on Respiratory Disease

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Vitamin E Supplementation on Hospital Stay Duration in Non-cyanotic Heart Disease Children With Lower Respiratory Tract Infections
Vitamin E - Respiratory Disease
Phase 4Not yet recruitingAssiut University2602025-06-012025-04-15
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
Nasal provocation test - 725 Dermatophagoides Pteronyssinus, Negative control - Mite Allergy, Respiratory Disease
Phase 4TerminatedCentre Hospitalier Régional Metz-Thionville82022-03-072024-08-09
The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
Nintedanib, Placebo - Pulmonary Fibrosis, Interstitial Lung Disease
Phase 4CompletedIcahn School of Medicine at Mount Sinai1032020-11-182026-11-16
Screening for Cancer in Patients With Unprovoked VTE
Fludeoxyglucose 18F - Venous Thromboembolic Disease, Respiratory Disease
Phase 4UnknownFundación Pública Andaluza para la gestión de la Investigación en Sevilla6502019-10-232021-12-09
A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients
YMC026, Placebo - Respiratory Disease
Phase 4CompletedYuhan Corporation2232017-10-272019-01-16

Narrower conditions

Respiration Disorders (5)  ·  COVID-19 (1)  ·  Cicatrix (1)  ·  Fibrosis (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Pulmonary Embolism (1)  ·  Pulmonary Fibrosis (1)  ·  Venous Thrombosis (1)

Broader conditions

Respiratory Tract Diseases (5)  ·  Cardiovascular Diseases (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Embolism (1)  ·  Embolism and Thrombosis (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Infections (1)

Interventions

Antigens, Dermatophagoides (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Vitamin E (1)  ·  nintedanib (1)

Sponsors

Assiut University (1)  ·  Centre Hospitalier Régional Metz-Thionville (1)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Yuhan Corporation (1)

Countries

France (1)  ·  South Korea (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Luis Jara Palomares, MD/PhD (1)  ·  Maria Padilla, MD (1)

Results publications

PMID 39971173, PMID 40216412

NIH funding

2018 (2)